Cargando…

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda

BACKGROUND: With the scale-up of antiretroviral therapy (ART), monitoring programme performance is needed to maximize ART efficacy and limit HIV drug resistance (HIVDR). METHODS: We implemented a WHO HIVDR prospective survey protocol at three treatment centers between 2012 and 2013. Data were abstra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaleebu, Pontiano, Kirungi, Wilford, Watera, Christine, Asio, Juliet, Lyagoba, Fred, Lutalo, Tom, Kapaata, Anne A., Nanyonga, Faith, Parry, Chris M., Magambo, Brian, Nazziwa, Jamirah, Nannyonjo, Maria, Hughes, Peter, Hladik, Wolfgang, Ruberantwari, Anthony, Namuwenge, Norah, Musinguzi, Joshua, Downing, Robert, Katongole-Mbidde, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689474/ https://www.ncbi.nlm.nih.gov/pubmed/26700639 http://dx.doi.org/10.1371/journal.pone.0145536

Ejemplares similares

Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations
por: Asio, Juliet, et al.
Publicado: (2020)

HIV drug resistance among adults initiating antiretroviral therapy in Uganda
por: Watera, Christine, et al.
Publicado: (2021)

Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda
por: Ssemwanga, Deogratius, et al.
Publicado: (2020)

Evaluation of HIV-1 rapid tests and identification of alternative testing algorithms for use in Uganda
por: Kaleebu, Pontiano, et al.
Publicado: (2018)

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
por: Namakoola, Ivan, et al.
Publicado: (2016)

Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda
por: Omooja, Jonah, et al.
Publicado: (2019)

HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach
por: Kiwuwa-Muyingo, Sylvia, et al.
Publicado: (2017)

Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans
por: Serwanga, Jennifer, et al.
Publicado: (2009)

Lack of Effectiveness of Antiretroviral Therapy in Preventing HIV Infection in Serodiscordant Couples in Uganda: An Observational Study
por: Birungi, Josephine, et al.
Publicado: (2015)

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
por: Sutherland, Katherine A., et al.
Publicado: (2016)

Effect of HIV-1 Subtypes on Disease Progression in Rural Uganda: A Prospective Clinical Cohort Study
por: Ssemwanga, Deogratius, et al.
Publicado: (2013)

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy
por: Kyosiimire-Lugemwa, Jacqueline, et al.
Publicado: (2020)

The Molecular Epidemiology and Transmission Dynamics of HIV Type 1 in a General Population Cohort in Uganda
por: Ssemwanga, Deogratius, et al.
Publicado: (2020)

‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
por: Mayanja, Yunia, et al.
Publicado: (2017)

The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS – ‘25 years of research through partnerships’
por: Kaleebu, P, et al.
Publicado: (2015)

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda
por: Birungi, J, et al.
Publicado: (2019)

A Qualitative Exploration of Causes of Depression among Persons Living with HIV Receiving Antiretroviral Therapy in Uganda: Implications for Policy
por: Rutakumwa, Rwamahe, et al.
Publicado: (2023)

P16-03. Persistence of robust cross-reactive group M consensus T-cell responses in a chronic HIV-1 clade A1 and D-infected Ugandan population
por: Serwanga, JJ, et al.
Publicado: (2009)

Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy
por: Kazooba, Patrick, et al.
Publicado: (2017)

The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis
por: Salome, Tino, et al.
Publicado: (2016)

COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort
por: Mayanja, Billy Nsubuga, et al.
Publicado: (2017)

Antiretroviral therapy and changing patterns of HIV stigmatisation in Entebbe, Uganda
por: Russell, Steve, et al.
Publicado: (2016)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
por: Mugenyi, Levicatus, et al.
Publicado: (2023)

Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy–evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011
por: Kazooba, Patrick, et al.
Publicado: (2018)

High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study
por: Nabitaka, Vennie Mbaziira, et al.
Publicado: (2020)

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
por: Lutalo, Tom, et al.
Publicado: (2021)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda
por: Okoboi, Stephen, et al.
Publicado: (2018)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles()
por: Serwanga, Jennifer, et al.
Publicado: (2015)

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016)

1564 Duration of Viral Suppression and objectively measured Antiretroviral Adherence as predictors of rebound Viremia in South Western Uganda
por: Musinguzi, Nicholas
Publicado: (2014)

Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda
por: Masiira, Ben, et al.
Publicado: (2014)

The Role of Phylogenetics in Discerning HIV-1 Mixing among Vulnerable Populations and Geographic Regions in Sub-Saharan Africa: A Systematic Review
por: Nduva, George M., et al.
Publicado: (2021)

Feasibility and acceptability of mobile phone short message service as a support for patients receiving antiretroviral therapy in rural Uganda: a cross-sectional study
por: Kim, Jiho, et al.
Publicado: (2015)

Finding Meaning: HIV Self-Management and Wellbeing among People Taking Antiretroviral Therapy in Uganda
por: Russell, Steve, et al.
Publicado: (2016)

Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries
por: Marston, Milly, et al.
Publicado: (2016)

Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples
por: Nalumansi, Aminah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04fu4tm5dnrde64sdurb3m3vl6